Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice. ANX-131 is an investigational drug that has not been approved by the FDA or other global regulatory bodies. By [Your Name/Handle]
For decades, the treatment of Generalized Anxiety Disorder (GAD) and post-traumatic stress disorder (PTSD) has been a pharmacological balancing act. On one side, you have benzodiazepines (Xanax, Valium)—effective but highly addictive, with tolerance and withdrawal risks. On the other, you have SSRIs (Zoloft, Prozac)—safe but slow-acting, with side effects that often make patients quit before they work. ANX-131
But what if there was a third path? Enter , a novel, oral, negative allosteric modulator (NAM) of the GABAA receptor. you have benzodiazepines (Xanax